SDAD1P4

Across TCGA pan-cancer cohorts, SDAD1P4 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated SDAD1P4 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher SDAD1P4 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SDAD1P4 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

SKCM, BLCA, and LIHC are the cancer types where SDAD1P4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Tertile	IV	0.179	0.755	<.001	63	view →
BLCA	DFS	Tertile	III,IV	0.247	0.556	.001	60	view →
LIHC	OS	Tertile	II,III,IV	0.059	0.772	<.001	36	view →
HNSC	DFS	Tertile	II,III,IV	0.923	0.630	.027	30	view →
COAD	OS	Tertile	II,III,IV	0.116	0.643	.044	27	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	18	view →
OV	DFS	Tertile	IV	0.237	0.491	.014	18	view →
ESCA	DFS	Tertile	II,III,IV	0.384	0.553	.032	12	view →
KIRC	OS	Tertile	All	0.531	0.687	.017	12	view →
SARC	OS	Tertile	All	0.241	0.614	.023	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

SDAD1P4–SKCM (OS)

Open the SKCM breakdown →